Precision Medicine
The Dementia with Lewy Bodies Consortium, funded by the National Institutes of Health, will work to identify biomarkers and advance disease detection, diagnosis, and measurement.
Speakers at the Precision Medicine Summit see a genomic future fueled by startups whose innovations outpace EHR vendors.
In addition, the industry must ensure better access to broadband to make telehealth a reality for underserved areas.
While doctors want to know everything they can, public health is far more cautionary when it comes to screenings.
Privacy protections, fraud guidelines and issues with discrimination need to be addressed before widespread adoption, expert says.
Eric Dishman, director of the All of Us Research Program, explains the goals of the landmark genomics initiative – and explains how his own personal experience with whole-genome sequencing has informed his work.
Development of evidence-based services for guiding treatment decisions within EHRs and care plan workflows is expected to be an outcome of two new acquisitions.
In fact, researchers said genetic sequencing could become less relevant in the near future.
No, that’s not a joke. It’s also about economic solvency and workforce productivity.
CRISPR-Cas9 could soon transform patient care, but process efficacy needs to be honed and delivery technology needs to be refined first.